Editas Medicine
EDIT
EDIT
193 hedge funds and large institutions have $51M invested in Editas Medicine in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 44 increasing their positions, 59 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
-10
Holders Change %
-4.93%
% of All Funds
2.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
44
Reduced
59
Closed
34
Calls
$668K
Puts
$339K
Net Calls
+$329K
Net Calls Change
+$321K
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$1.66M |
| 2 |
Morgan Stanley
New York
|
+$1.3M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.26M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$746K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$645K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$2.86M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.65M |
| 3 |
Goldman Sachs
New York
|
-$1.41M |
| 4 |
MAM
Monaco Asset Management
Monaco
|
-$1.36M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.06M |
